Microbix Biosystems Inc. to Build Flu Vaccine Plant in China

TORONTO, June 23 (Reuters) - Microbix Biosystems Inc plans to build and operate a new influenza vaccine plant in China, which will be one of the largest facilities in the world, the Canadian biotechnology firm said on Monday.
MORE ON THIS TOPIC